AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	224,049	133,010	81,183	63,886	75,255	59,789
Market Cap Growth	32.43%	63.84%	27.07%	-15.11%	25.87%	19.68%
Enterprise Value	219,252	127,861	76,552	60,484	72,857	57,477
Last Close Price	8967.50	5310.51	3228.09	2525.57	2976.40	2376.15
PE Ratio	231.05	82.35	81.76	103.71	80.66	82.80
PS Ratio	13.84	10.27	8.09	7.93	9.25	7.19
PB Ratio	32.98	18.68	13.79	12.49	16.50	16.41
P/TBV Ratio	33.07	18.74	13.79	12.49	16.50	16.41
P/FCF Ratio	-	777.38	163.12	70.07	77.53	81.68
P/OCF Ratio	-	477.25	139.27	63.38	71.82	68.39
EV/Sales Ratio	13.54	9.87	7.63	7.51	8.96	6.91
EV/EBITDA Ratio	105.87	69.81	47.45	73.16	54.94	48.72
EV/EBIT Ratio	113.70	74.58	51.43	87.20	62.67	56.04
EV/FCF Ratio	-	747.29	153.81	66.33	75.06	78.52
Debt / Equity Ratio	0.03	0.01	0.01	0.02	0.03	0.03
Debt / EBITDA Ratio	0.08	0.02	0.04	0.10	0.09	0.10
Debt / FCF Ratio	-	0.27	0.14	0.10	0.13	0.16
Asset Turnover	-	1.26	1.09	0.99	1.10	1.31
Inventory Turnover	-	2.87	2.22	2.11	1.85	2.20
Quick Ratio	-	1.89	1.61	1.64	1.46	1.06
Current Ratio	-	2.61	2.18	2.12	2.04	1.66
Return on Equity (ROE)	-	24.84%	18.05%	12.73%	22.74%	21.71%
Return on Assets (ROA)	-	10.39%	10.11%	5.32%	9.81%	10.11%
Return on Capital (ROIC)	17.77%	16.33%	16.67%	8.77%	17.21%	18.93%
Return on Capital Employed (ROCE)	-	23.80%	24.80%	13.20%	24.70%	27.10%
Earnings Yield	0.43%	1.21%	1.22%	0.96%	1.24%	1.21%
FCF Yield	-	0.13%	0.61%	1.43%	1.29%	1.22%
Dividend Yield	0.27%	0.45%	0.50%	0.40%	0.07%	0.04%
Payout Ratio	-	24.77%	20.14%	8.12%	5.36%	3.46%
Total Shareholder Return	0.26%	0.45%	0.50%	0.40%	0.07%	0.04%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.